Endometrial / Uterine Cancer Treatment
Home / Endometrial / Uterine Cancer Treatment
Endometrial Cancer Treatment – Precision Care for Uterine Malignancies
Endometrial cancer, also called uterine cancer, is the most common gynecologic malignancy in developed countries. Fortunately, most cases are diagnosed at early stages due to the warning sign of postmenopausal bleeding, and treatment offers excellent cure rates when managed by subspecialty-trained oncologists.
Dr. Aiswarya Sekar provides comprehensive endometrial cancer care using advanced surgical techniques, molecular marker-based treatment planning, and evidence-based approaches tailored to each patient’s unique situation.
Understanding Endometrial Cancer
Endometrial cancer develops in the endometrium, the lining of the uterus. Unlike many cancers that grow silently, endometrial cancer typically causes abnormal vaginal bleeding, prompting early medical evaluation and diagnosis.
Types of Endometrial Cancer
Type I (Endometrioid)
The most common subtype (about 80% of cases), usually related to estrogen exposure. These cancers tend to be lower grade and have favorable prognosis.
Type II (Non-endometrioid)
Includes serous, clear cell, and carcinosarcoma subtypes. These aggressive cancers require more intensive treatment even at early stages.
Recent advances in molecular classification now guide treatment decisions beyond traditional histologic typing, allowing more personalized approaches.
Risk Factors
- Postmenopausal status
- Obesity
- Diabetes and metabolic syndrome
- Unopposed estrogen exposure (estrogen without progesterone)
- Tamoxifen use for breast cancer
- Lynch syndrome (hereditary cancer syndrome)
- Polycystic ovary syndrome (PCOS)
- Never having been pregnant
Symptoms and Diagnosis
Warning Signs
- Postmenopausal bleeding – Any vaginal bleeding after menopause requires evaluation
- Abnormal bleeding in premenopausal women – Irregular, heavy, or prolonged menstrual bleeding
- Abnormal vaginal discharge
- Pelvic pain (usually in advanced cases)
Diagnostic Evaluation
Endometrial Biopsy
An office procedure using a thin catheter to sample uterine lining tissue. This simple test provides diagnosis in most cases.
Transvaginal Ultrasound
Measures endometrial thickness and identifies abnormalities. Thickened endometrium in postmenopausal women requires biopsy.
Hysteroscopy
Direct visualization of the uterine cavity using a thin camera, allowing targeted biopsy of abnormal areas. Dr. Aiswarya performs diagnostic hysteroscopy when office biopsy is inadequate or when direct visualization is needed.
Imaging Studies
MRI, CT, or PET scans assess tumor size, invasion depth, and potential spread to lymph nodes or distant sites.
Surgical Staging and Treatment
Surgery provides both staging information and treatment for most endometrial cancers. The standard procedure involves:
Hysterectomy and Bilateral Salpingo-Oophorectomy
- Removal of uterus, cervix, both fallopian tubes, and both ovaries
- Provides definitive treatment for cancer confined to the uterus
- Pathologic examination determines cancer grade, invasion depth, and other risk factors
Lymph Node Assessment
Whether and how to evaluate lymph nodes depends on tumor characteristics:
Sentinel Lymph Node Mapping
An advanced technique that identifies the specific lymph nodes most likely to contain cancer. A dye is injected into the cervix, and only the “sentinel” nodes that light up are removed for examination.
Benefits include:
- Accurate staging with removal of fewer nodes
- Dramatically reduced risk of leg lymphedema
- Faster recovery
Dr. Aiswarya routinely performs sentinel lymph node mapping for appropriate endometrial cancer patients, having received specialized training in this technique.
Complete Lymphadenectomy
Removal of all pelvic and sometimes para-aortic lymph nodes. Reserved for high-risk cancers or when sentinel mapping cannot be performed.
Minimally Invasive Surgery
For most endometrial cancers, Dr. Aiswarya performs surgery using minimally invasive approaches:
Laparoscopic Surgery
Small incisions allow removal of the uterus and staging procedures with:
- Less postoperative pain
- Shorter hospital stay (often same-day or overnight)
- Faster return to normal activities
- Lower risk of wound complications
- Equivalent cancer outcomes compared to open surgery
Robotic Surgery
Robotic-assisted surgery provides enhanced visualization and precision, particularly beneficial for complex cases or when extensive lymph node dissection is needed.
Open Surgery
Traditional abdominal surgery may be recommended for:
- Very large uterus
- Extensive disease requiring complex resection
- Medical conditions preventing minimally invasive approach
Molecular Classification and Treatment Planning
Advances in molecular testing now guide endometrial cancer treatment. Four molecular subtypes have been identified:
- POLE-mutated – Excellent prognosis, may need less intensive treatment
- Mismatch repair deficient (dMMR) – Linked to Lynch syndrome, responds to immunotherapy
- p53-abnormal – Aggressive subtype requiring more intensive treatment
- No specific molecular profile (NSMP) – Intermediate prognosis
Dr. Aiswarya coordinates molecular testing and uses results to personalize treatment recommendations, avoiding overtreatment in low-risk cases and ensuring adequate treatment for high-risk subtypes.
Molecular Classification and Treatment Planning
After completing treatment, regular follow-up appointments monitor for recurrence and address quality-of-life concerns:
- Physical examination and symptom review
- CA-125 testing when indicated
- Imaging studies if symptoms suggest recurrence
- Management of treatment side effects
- Menopause symptom management
- Emotional and psychological support
Dr. Aiswarya provides comprehensive survivorship care, addressing both medical and quality-of-life needs throughout the cancer journey.
Adjuvant Treatment
After surgery, pathology results determine whether additional treatment is needed:
Low-Risk Features
- Early stage (IA)
- Low grade (Grade 1 or 2)
- Favorable molecular profile
Treatment: Observation with regular follow-up; no additional therapy needed.
Intermediate-Risk Features
- Superficial invasion with unfavorable features
- Deep invasion in small tumors
Treatment: Vaginal brachytherapy (internal radiation to vaginal cuff) reduces local recurrence risk without need for external radiation.
High-Risk Features
- Deep invasion
- High grade (Grade 3)
- Aggressive histology (serous, clear cell)
- Lymph node involvement
Treatment: Combination chemotherapy and radiation therapy; immunotherapy for dMMR tumors.
Dr. Aiswarya works closely with medical and radiation oncologists to ensure seamless coordination of adjuvant treatment.
Fertility-Sparing Treatment
Young women with early-stage, low-grade endometrial cancer who desire future pregnancy may be candidates for non-surgical management:
Hormonal Therapy
High-dose progesterone can sometimes reverse early endometrial cancer, allowing preservation of the uterus. This requires:
- Very early-stage, low-grade cancer
- Careful monitoring with repeat biopsies
- Understanding that cancer may recur
- Pregnancy attempts as soon as medically safe
Dr. Aiswarya provides comprehensive counseling about fertility-sparing options, helping young women understand success rates, monitoring requirements, and risks to make informed decisions.
Management After Incomplete Surgery
If you underwent hysterectomy for presumed benign reasons and cancer was unexpectedly found on pathology, additional surgery may be recommended to:
- Remove ovaries and fallopian tubes
- Perform lymph node assessment
- Ensure complete staging for treatment planning
Dr. Aiswarya evaluates pathology reports and imaging to determine whether completion staging is needed and discusses recommendations based on your individual situation.
Treatment of Recurrent Disease
When endometrial cancer returns after initial treatment, options depend on location and extent of recurrence:
- Surgery for isolated vaginal or pelvic recurrences
- Radiation therapy for local recurrences
- Chemotherapy for distant spread
- Immunotherapy for dMMR tumors
- Hormonal therapy for select cases
- Clinical trials of novel agents
Hereditary Endometrial Cancer
About 5% of endometrial cancers are associated with Lynch syndrome, a hereditary cancer syndrome also increasing risks of colon, ovarian, and other cancers. Women with endometrial cancer diagnosed before age 50, or with specific pathologic features, should undergo genetic testing.
Lynch syndrome testing impacts:
- Surveillance recommendations for other cancers
- Family member risk assessment
- Treatment decisions (immunotherapy eligibility)
Dr. Aiswarya coordinates genetic testing and provides counseling about results and implications for patients and families.
Follow-Up and Survivorship
After completing endometrial cancer treatment, regular follow-up includes:
- Physical examination every 3-6 months for first few years
- Vaginal cytology when indicated
- Prompt evaluation of any new symptoms
- Imaging studies if recurrence suspected
- Management of menopausal symptoms
- Addressing quality-of-life concerns
Most recurrences occur within three years of initial diagnosis, making regular follow-up essential.
Managing Treatment Side Effects
Surgical Recovery
Minimally invasive surgery allows quick recovery, with most women returning to normal activities within 2-4 weeks. Specific considerations include:
- Menopause management in premenopausal women
- Sexual health and vaginal changes
- Psychological adjustment
Radiation Side Effects
Pelvic radiation can affect bowel, bladder, and sexual function. Dr. Aiswarya coordinates with radiation oncologists to minimize side effects while ensuring effective treatment.
Chemotherapy Side Effects
Neuropathy, fatigue, and other chemotherapy side effects are managed in coordination with medical oncologists.
Why Subspecialty Expertise Matters
Endometrial cancer treatment has evolved significantly with introduction of minimally invasive surgery, sentinel lymph node mapping, and molecular classification. Gynecologic oncologists:
- Perform appropriate staging procedures
- Use advanced surgical techniques to minimize complications
- Integrate molecular testing into treatment planning
- Coordinate optimal adjuvant therapy
- Provide comprehensive survivorship care
Compassionate, Evidence-Based Care
Every woman’s endometrial cancer situation is unique. Dr. Aiswarya takes time to explain your diagnosis, discuss treatment options including fertility-sparing approaches when appropriate, and develop a personalized plan aligned with your goals and values.
If you’ve been diagnosed with endometrial cancer or have concerning symptoms like postmenopausal bleeding, specialized consultation ensures optimal treatment. Contact us today to schedule an appointment.